-
From Bharathi Vennapusa on January 31st, 2021
1 likes 6 playsDrs. Bharathi Vennapusa, Denise Croix and Katie Robertson discuss overview of NTRK fusions, testing methods, algorithms with a focus on pan-TRK IHC assay using VENTANA… -
From Bharathi Vennapusa on October 10th, 2020
0 likes 23 playsDown the Ocular Episode # 2: VENTANA pan-TRK (EPR17341) Assay: This episode focuses on the NTRK fusions; their detection, the testing methodologies used, and their role… -
From Bharathi Vennapusa on November 19th, 2020
0 likes 0 playsBrief video on scoring algorithm for VENTANA HER2 Dual ISH DNA Probe Cocktail. Content and approvals of any product related information is current as of the date of… -
From Bharathi Vennapusa on November 19th, 2020
0 likes 3 playsThis is episode 4 of the Down the Ocular podcast. In this episode, Roche Tissue Diagnostics Medical and Scientific Affairs colleagues Bharathi Vennapusa, MD and Tabari… -
From Bharathi Vennapusa on November 20th, 2020
0 likes 2 playsIn this episode, Roche Tissue Diagnostics Medical and Scientific Affairs colleagues Bharathi Vennapusa, MD and Tabari Baker, PhD discuss the use of digital pathology… -
From Bharathi Vennapusa on November 20th, 2020
0 likes 4 playsIn this episode, Roche Tissue Diagnostics Medical and Scientific Affairs colleagues Bharathi Vennapusa, MD and Tabari Baker, PhD discuss the PD-L1 (SP142) assay in… -
From Bharathi Vennapusa on November 20th, 2020
0 likes 1 playsThis episode is part 2 in a series on the PD-L1 (SP142) assay in non small cell lung cancer. In this episode, Roche Tissue Diagnostics Medical and Scientific Affairs… -
From Bharathi Vennapusa on November 20th, 2020
0 likes 8 playsDr. Bharathi Vennapusa from Roche MSA discusses Pan-TRK IHC using VENTANA pan-TRK (EPR17341) Assay. Content and approvals of any product related info is current as of… -
From Bharathi Vennapusa on November 20th, 2020
0 likes 4 playsDr. Bharathi Vennapusa from Roche MSA discusses 2018 CAP/ASCO HER2 guideline update and how it pertains to Roche HER2 Assays. Content and approvals of any product… -
From Bharathi Vennapusa on November 20th, 2020
0 likes 14 playsDr. Denise Croix from Roche MSA discusses NTRK fusions biology and testing methods. Content and approvals of any product related info is current as of the date of… -
From Bharathi Vennapusa on November 20th, 2020
0 likes 11 playsDr. Bharathi Vennapusa from Roche MSA reviews example cases stained with VENTANA pan-TRK (EPR17341) Assay using digital slides. Content and approvals of any product… -
From Bharathi Vennapusa on November 20th, 2020
0 likes 12 playsDr. Katie Robertson from Roche MSA discusses testing algorithms for NTRK fusion testing. Content and approvals of any product related info is current as of the date of… -
From Bharathi Vennapusa on November 22nd, 2020
0 likes 3 playsUS Pathologist, Dr. Michael Lynch, from the Medical and Scientific Affairs (MSA) department for Roche Tissue Diagnostics discusses the tumor microenvironment, the cancer… -
From Bharathi Vennapusa on November 22nd, 2020
0 likes 8 playsUS Pathologist, Dr. Michael Lynch, from the Medical and Scientific Affairs (MSA) department for Roche Tissue Diagnostics discusses: 1. How and why PD-L1 is present on… -
From Bharathi Vennapusa on November 22nd, 2020
0 likes 7 playsUS Pathologist, Dr. Michael Lynch, from the Medical and Scientific Affairs (MSA) department for Roche Tissue Diagnostics discusses on: 1. The PD-L1 biomarker and its…
Search for ""
Public, Open and Moderated
- Managers:
- Appears In: